Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
4 hedge funds and large institutions have $18K invested in Guardion Health Sciences, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$22.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.71K |
| 3 |
BlackRock
New York
|
+$1.18K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$589 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $14K | +$22.4K | +38 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $3K | +$4.71K | +8 | New |
|
|
3
BlackRock
New York
| $1K | +$1.18K | +2 | New |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | +$589 | +1 | New |
|
GHSI Hedge Fund Activity: Q2 2019 in Review
4 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q2 2019, worth a combined $18K.
Buyers outnumbered sellers: 4 funds opened new GHSI positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $22.4K.
- 4 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $18K of Guardion Health Sciences, Inc. Common Stock stock for Q2 2019.
- 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q2 2019 and 0 closed out, a net change of +4 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q2 2019 was Citadel Advisors, an estimated $22.4K added.
Based on aggregated 13F filings for Q2 2019.